435 related articles for article (PubMed ID: 11273992)
1. Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium.
Moniotte S; Kobzik L; Feron O; Trochu JN; Gauthier C; Balligand JL
Circulation; 2001 Mar; 103(12):1649-55. PubMed ID: 11273992
[TBL] [Abstract][Full Text] [Related]
2. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling.
Molenaar P; Savarimuthu SM; Sarsero D; Chen L; Semmler AB; Carle A; Yang I; Bartel S; Vetter D; Beyerdörfer I; Krause EG; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):11-28. PubMed ID: 17295024
[TBL] [Abstract][Full Text] [Related]
3. Subsensitivity of the failing human heart to isoprenaline and milrinone is related to beta-adrenoceptor downregulation.
Böhm M; Diet F; Feiler G; Kemkes B; Kreuzer E; Weinhold C; Erdmann E
J Cardiovasc Pharmacol; 1988 Dec; 12(6):726-32. PubMed ID: 2467092
[TBL] [Abstract][Full Text] [Related]
4. Effects of the beta3-adrenergic agonist BRL 37344 on endothelial nitric oxide synthase phosphorylation and force of contraction in human failing myocardium.
Napp A; Brixius K; Pott C; Ziskoven C; Boelck B; Mehlhorn U; Schwinger RH; Bloch W
J Card Fail; 2009 Feb; 15(1):57-67. PubMed ID: 19181295
[TBL] [Abstract][Full Text] [Related]
5. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H
Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446
[TBL] [Abstract][Full Text] [Related]
6. Effect of inotropic interventions on the force-frequency relation in the human heart.
Bavendiek U; Brixius K; Münch G; Zobel C; Müller-Ehmsen J; Schwinger RH
Basic Res Cardiol; 1998; 93 Suppl 1():76-85. PubMed ID: 9833134
[TBL] [Abstract][Full Text] [Related]
7. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Schmitz W; Scholz H; Starbatty J; Stein B; Wenzlaff H
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):90-100. PubMed ID: 1723153
[TBL] [Abstract][Full Text] [Related]
8. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart.
Drexler H; Kästner S; Strobel A; Studer R; Brodde OE; Hasenfuss G
J Am Coll Cardiol; 1998 Oct; 32(4):955-63. PubMed ID: 9768717
[TBL] [Abstract][Full Text] [Related]
9. Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy.
Brodde OE; Vogelsang M; Broede A; Michel-Reher M; Beisenbusch-Schäfer E; Hakim K; Zerkowski HR
J Cardiovasc Pharmacol; 1998 Apr; 31(4):585-94. PubMed ID: 9554809
[TBL] [Abstract][Full Text] [Related]
10. Increased contribution of alpha 1- vs. beta-adrenoceptor-mediated inotropic response in rats with congestive heart failure.
Sjaastad I; Schiander I; Sjetnan A; Qvigstad E; Bøkenes J; Sandnes D; Osnes JB; Sejersted OM; Skomedal T
Acta Physiol Scand; 2003 Apr; 177(4):449-58. PubMed ID: 12648162
[TBL] [Abstract][Full Text] [Related]
11. Influence of forskolin on the force-frequency behavior in nonfailing and end-stage failing human myocardium.
Pieske B; Trost S; Schütt K; Minami K; Just H; Hasenfuss G
Basic Res Cardiol; 1998; 93 Suppl 1():66-75. PubMed ID: 9833133
[TBL] [Abstract][Full Text] [Related]
12. Regulation and possible functional implications of G-protein mRNA expression in nonfailing and failing ventricular myocardium.
Eschenhagen T; Mende U; Nose M; Schmitz W; Scholz H; Schulte am Esch J; Sempell R; Warnholtz A; Wüstel JM
Basic Res Cardiol; 1992; 87 Suppl 1():51-64. PubMed ID: 1497578
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure.
Stein B; Eschenhagen T; Rüdiger J; Scholz H; Förstermann U; Gath I
J Am Coll Cardiol; 1998 Nov; 32(5):1179-86. PubMed ID: 9809923
[TBL] [Abstract][Full Text] [Related]
14. Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity.
Böhm M; Mittmann C; Schwinger RH; Erdmann E
Am Heart J; 1990 Dec; 120(6 Pt 1):1381-92. PubMed ID: 1978979
[TBL] [Abstract][Full Text] [Related]
15. Positive and negative inotropic effects of DL-sotalol and D-sotalol in failing and nonfailing human myocardium under physiological experimental conditions.
Holubarsch C; Schneider R; Pieske B; Ruf T; Hasenfuss G; Fraedrich G; Posival H; Just H
Circulation; 1995 Nov; 92(10):2904-10. PubMed ID: 7586258
[TBL] [Abstract][Full Text] [Related]
16. Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart.
Port JD; Gilbert EM; Larrabee P; Mealey P; Volkman K; Ginsburg R; Hershberger RE; Murray J; Bristow MR
Circulation; 1990 Mar; 81(3):929-38. PubMed ID: 1968367
[TBL] [Abstract][Full Text] [Related]
17. Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors.
Heubach JF; Blaschke M; Harding SE; Ravens U; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):380-90. PubMed ID: 12690430
[TBL] [Abstract][Full Text] [Related]
18. Positive inotropic effects of the novel Na+-channel modulator BDF 9198 in human nonfailing and failing myocardium.
Müller-Ehmsen J; Brixius K; Schwinger RH
J Cardiovasc Pharmacol; 1998 May; 31(5):684-9. PubMed ID: 9593067
[TBL] [Abstract][Full Text] [Related]
19. Specific beta(2)AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heart.
Gong H; Sun H; Koch WJ; Rau T; Eschenhagen T; Ravens U; Heubach JF; Adamson DL; Harding SE
Circulation; 2002 May; 105(21):2497-503. PubMed ID: 12034656
[TBL] [Abstract][Full Text] [Related]
20. Human Myocardium Has a Robust α1A-Subtype Adrenergic Receptor Inotropic Response.
Janssen PML; Canan BD; Kilic A; Whitson BA; Baker AJ
J Cardiovasc Pharmacol; 2018 Sep; 72(3):136-142. PubMed ID: 29923888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
